Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-14

Clinical Trial Update: NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the NEW DAY program focusing on nutrition, exercise, weight loss, and diabetes management. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 2 | Status: COMPLETED